20-Feb-25 |
Exercise of option |
Carl Kindinger |
5.50p | 7,500,000 |
£412,500.00 |
20-Feb-25 |
Exercise of option |
Alistair Jury |
5.50p | 7,500,000 |
£412,500.00 |
20-Feb-25 |
Exercise of option |
Paul Stanard Griffiths |
5.00p | 18,500,000 |
£925,000.01 |
20-Feb-25 |
Exercise of option |
Stephen A R Boldy |
5.50p | 7,500,000 |
£412,500.00 |
20-Feb-25 |
Exercise of option |
Paul Stanard Griffiths |
5.00p | 18,500,000 |
£925,000.01 |
20-Feb-25 |
Exercise of option |
Stephen A R Boldy |
5.50p | 7,500,000 |
£412,500.00 |
20-Feb-25 |
Exercise of option |
Alistair Jury |
5.50p | 7,500,000 |
£412,500.00 |
20-Feb-25 |
Exercise of option |
Carl Kindinger |
5.50p | 7,500,000 |
£412,500.00 |
Paul Stanard Griffiths |
18,500,000 |
£578,125 |
Carl Kindinger |
7,921,052 |
£247,533 |
Alistair Jury |
7,500,000 |
£234,375 |
Stephen A R Boldy |
7,500,000 |
£234,375 |
Lonny Baumgardner |
555,600 |
£17,362 |
Paul Stanard Griffiths |
46,415,581 |
£1,450,487 |
The Bank of New York |
37,688,501 |
£1,177,766 |
Lonny James Baumgardner |
29,079,819 |
£908,744 |
Barclays Direct Investing Nominees Limited |
16,303,817 |
£509,494 |
Vidacos Nominees Limited |
9,494,895 |
£296,716 |
HSDL Nominees Limited |
8,282,530 |
£258,829 |
Killik & Co |
3,571,400 |
£111,606 |
Top of Page
You are here:
research